BRI projects face a multiplicity of issues from procurement to implementation. Investors must thoroughly understand and mitigate risks associated with BRI ventures.
The U.S. adds 12 Chinese entities to its export blacklist; Rules regulating listed companies to be consolidated; Didi ordered by regulators to delist from NYSE
New rules are set forth for foreign-related certification. More details are required for working papers of securities offering sponsorship. Domestic bond credit rating is relied on more for insurance capital investment.
Hong Kong finalizes secondary listing reforms to attract more Greater China Issuers; SAMR fines tech giants for failing to declare transactions; and German insurer Allianz approved to take full control of life insurance business
In China's first-ever securities class action, Kangmei Pharmaceuticals has been ordered to pay $385 million as compensation—just enough for 50,000 investors to recoup their losses.
